[HTML][HTML] Role of diagnostic factors associated with antioxidative status and expression of matrix metalloproteinases (MMPs) in patients with cancer therapy induced …
Background Cancer patients when treated with different chemotherapeutic drugs often
develop mild to severe sight threatening diseases during or after chemotherapy. The …
develop mild to severe sight threatening diseases during or after chemotherapy. The …
[HTML][HTML] Role of diagnostic factors associated with antioxidative status and expression of matrix metalloproteinases (MMPs) in patients with cancer therapy induced …
M Rasool, A Malik, MAB Ashraf, M Arooj… - Saudi Journal of …, 2018 - ncbi.nlm.nih.gov
Background Cancer patients when treated with different chemotherapeutic drugs often
develop mild to severe sight threatening diseases during or after chemotherapy. The …
develop mild to severe sight threatening diseases during or after chemotherapy. The …
[PDF][PDF] Role of diagnostic factors associated with antioxidative status and expression of matrix metalloproteinases (MMPs) in patients with cancer therapy induced …
M Rasool, A Malik, MAB Ashraf, M Arooj… - Saudi Journal of …, 2018 - academia.edu
abstract Background: Cancer patients when treated with different chemotherapeutic drugs
often develop mild to severe sight threatening diseases during or after chemotherapy. The …
often develop mild to severe sight threatening diseases during or after chemotherapy. The …
[PDF][PDF] Role of diagnostic factors associated with antioxidative status and expression of matrix metalloproteinases (MMPs) in patients with cancer therapy induced …
M Rasool, A Malik, MAB Ashraf, M Arooj… - Saudi Journal of …, 2018 - scienceopen.com
abstract Background: Cancer patients when treated with different chemotherapeutic drugs
often develop mild to severe sight threatening diseases during or after chemotherapy. The …
often develop mild to severe sight threatening diseases during or after chemotherapy. The …
Role of diagnostic factors associated with antioxidative status and expression of matrix metalloproteinases (MMPs) in patients with cancer therapy induced ocular …
M Rasool, A Malik, MAB Ashraf, M Arooj, A Kiran… - 2018 - agris.fao.org
Background: Cancer patients when treated with different chemotherapeutic drugs often
develop mild to severe sight threatening diseases during or after chemotherapy. The …
develop mild to severe sight threatening diseases during or after chemotherapy. The …
Role of diagnostic factors associated with antioxidative status and expression of matrix metalloproteinases (MMPs) in patients with cancer therapy induced ocular …
M Rasool, A Malik, MAB Ashraf… - Saudi journal of …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Cancer patients when treated with different chemotherapeutic drugs often
develop mild to severe sight threatening diseases during or after chemotherapy. The …
develop mild to severe sight threatening diseases during or after chemotherapy. The …
Role of diagnostic factors associated with antioxidative status and expression of matrix metalloproteinases (MMPs) in patients with cancer therapy induced ocular …
M Rasool, A Malik… - Saudi Journal of …, 2018 - ui.adsabs.harvard.edu
Cancer patients when treated with different chemotherapeutic drugs often develop mild to
severe sight threatening diseases during or after chemotherapy. The mechanism involved in …
severe sight threatening diseases during or after chemotherapy. The mechanism involved in …
Role of diagnostic factors associated with antioxidative status and expression of matrix metalloproteinases (MMPs) in patients with cancer therapy induced ocular …
M Rasool, A Malik, MAB Ashraf, M Arooj… - Saudi Journal of …, 2018 - ksascholar.dri.sa
Background: Cancer patients when treated with different chemotherapeutic drugs often
develop mild to severe sight threatening diseases during or after chemotherapy. The …
develop mild to severe sight threatening diseases during or after chemotherapy. The …
Role of diagnostic factors associated with antioxidative status and expression of matrix metalloproteinases (MMPs) in patients with cancer therapy induced ocular …
M Rasool, A Malik, M Arooj, A Kiran… - Saudi Journal of …, 2018 - europepmc.org
Background Cancer patients when treated with different chemotherapeutic drugs often
develop mild to severe sight threatening diseases during or after chemotherapy. The …
develop mild to severe sight threatening diseases during or after chemotherapy. The …
[PDF][PDF] Role of diagnostic factors associated with antioxidative status and expression of matrix metalloproteinases (MMPs) in patients with cancer therapy induced …
M Rasool, A Malik, MAB Ashraf, M Arooj… - Saudi Journal of …, 2018 - academia.edu
abstract Background: Cancer patients when treated with different chemotherapeutic drugs
often develop mild to severe sight threatening diseases during or after chemotherapy. The …
often develop mild to severe sight threatening diseases during or after chemotherapy. The …